Caregivers of Dementia Patients: Mental Health Screening & Support

Author and Disclosure Information

Although accreditation for this CE/CME activity has expired, and the posttest is no longer available, you can still read the full article.

Expires May 31, 2017

Caregivers, mostly family and friends, play an important role in the complex care of persons with Alzheimer disease and other dementias. Primary care providers are uniquely positioned to assess for the negative consequences of caregiving, including depression, anxiety, and caregivers' failure to care for their own health needs. This article provides you with reliable, valid screening tools and recommendations for evidence-based interventions to increase the caregiver’s and patient’s quality of life and care.



CE/CME No: CR-1606

Earn credit by reading this article and successfully completing the posttest and evaluation. Successful completion is defined as a cumulative score of at least 70% correct.

• Describe the adverse consequences that caregivers of persons with Alzheimer disease or other dementias commonly experience.
• Identify reliable and validated tools in the public domain available for use in primary care settings to assess a caregiver's well-being.
• List interventions that are known to support and improve the lives of caregivers seeking care.
• Discuss the impact of support groups on depression and burden of care experienced by caregivers.
• Define the role of primary care providers in reducing the negative aspects of caregiving.


Nancy Langman is a mental health and public health nurse practitioner on Martha’s Vineyard and an Adjunct Clinical Instructor at the University of Massachusetts Amherst.
The author has no financial relationships to disclose.


This program has been reviewed and is approved for a maximum of 1.0 hour of American Academy of Physician Assistants (AAPA) Category 1 CME credit by the Physician Assistant Review Panel. [NPs: Both ANCC and the AANP Certification Program recognize AAPA as an approved provider of Category 1 credit.] Approval is valid for one year from the issue date of June 2016.

Article begins on next page >>


Next Article:

Despite Advances, Alzheimer’s Remains a Tricky Diagnosis

Related Articles